Massively parallel sequencing (MPS) is an exciting technology that holds promise for enhancing the capabilities of the forensic DNA analyst. However, there are several challenges that confront implementation of a MPS system into the crime laboratory, which include: training and education on fundamentals of the chemistry, functionality, and genetic marker systems; validation criteria and study design; policy and data procedure developments related to CODIS operations; and perceived admissibility and privacy issues. This four-part webinar series will address these and other areas of interest, providing foundational information on the two available MPS systems, covering platforms and chemistries, throughput, genetic markers, bioinformatics, validation requirements, applications, and potential admissibility issues.
In this second webinar, The Genetic Marker Potential, we will discuss the different genetic markers which can be typed, including the future roles and benefits of these markers, as well as considerations for CODIS compatibility and expansion. In addition, we will discuss the pros and cons of the different sized multiplexes. These discussion will clearly identify the potential benefits this promising technology can bring to forensic science.